Markets:

Overview

News

Currencies

International

Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.310 -0.020 (-0.86%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 05, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 29, 2022

Via Benzinga

Black Diamond Therapeutics Announces Changes to Board of Directors

December 19, 2022

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company

December 12, 2022

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

November 09, 2022

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 08, 2022

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

$3 Million Bet On Taysha Gene Therapies? Check Out These 3 Penny Stocks Insiders Are Buying ↗

November 03, 2022

The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Black Diamond Therapeutics And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

November 01, 2022

The Dow Jones closed lower by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

October 26, 2022

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying ↗

October 24, 2022

The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Why IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket ↗

October 14, 2022

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 80.1% to $0.4161 in pre-market trading after declining around 7% on Thursday. CONNEXA, last month, announced a $5.0 million private...

Via Benzinga

Black Diamond Therapeutic: Q2 Earnings Insights ↗

August 09, 2022

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying ↗

July 01, 2022

U.S. stocks opened slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

Black Diamond Therapeutic: Q1 Earnings Insights ↗

May 11, 2022

Black Diamond Therapeutic (NASDAQ:BDTX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

Via Benzinga

Executives Buy Around $1.6M Of 4 Penny Stocks ↗

May 02, 2022

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

Black Diamond Cuts 30% Of Its Workforce, Discontinues Drug From its 'MasterKey' Pipeline ↗

April 25, 2022

Black Diamond Therapeutics Inc (NASDAQ: BDTX) is realigning its resources to extend its cash runway into the third quarter of 2024.

Via Benzinga

Executives Buy Around $5M Of 3 Penny Stocks ↗

April 21, 2022

US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's...

Via Benzinga

4 Stocks Under $5 Insiders Are Aggressively Buying ↗

April 18, 2022

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

April 07, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022 ↗

March 29, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 18, 2022

Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9...

Via Benzinga

Why Black Diamond Therapeutics Stock Is Trading Higher Today ↗

January 11, 2022

Black Diamond Therapeutics Inc (NASDAQ: BDTX) is trading higher Tuesday after the company announced it received U.S. Food and Drug Administration clearance for...

Via Benzinga

The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗

January 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 11, 2022

Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 09, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.